These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 32157272
1. Impact of Low Muscle Mass and Low Muscle Strength According to EWGSOP2 and EWGSOP1 in Community-Dwelling Older People. Costanzo L, De Vincentis A, Di Iorio A, Bandinelli S, Ferrucci L, Antonelli Incalzi R, Pedone C. J Gerontol A Biol Sci Med Sci; 2020 Jun 18; 75(7):1324-1330. PubMed ID: 32157272 [Abstract] [Full Text] [Related]
2. European Working Group on Sarcopenia in Older People 2010 (EWGSOP1) and 2019 (EWGSOP2) criteria or slowness: which is the best predictor of mortality risk in older adults? Spexoto MCB, Ramírez PC, de Oliveira Máximo R, Steptoe A, de Oliveira C, Alexandre TDS. Age Ageing; 2022 Jul 01; 51(7):. PubMed ID: 35906934 [Abstract] [Full Text] [Related]
3. Sarcopenia and mortality risk in community-dwelling Brazilian older adults. Pereira CC, Pagotto V, de Oliveira C, Silveira EA. Sci Rep; 2022 Oct 20; 12(1):17531. PubMed ID: 36266412 [Abstract] [Full Text] [Related]
5. Associations of EWGSOP1 and EWGSOP2 probable sarcopenia definitions with mortality: A comparative study. Altinkaynak M, Gurel E, Oren MM, Kilic C, Karan MA, Bahat G. Clin Nutr; 2023 Nov 20; 42(11):2151-2158. PubMed ID: 37774651 [Abstract] [Full Text] [Related]
8. Comparison of the 2010 and 2019 diagnostic criteria for sarcopenia by the European Working Group on Sarcopenia in Older People (EWGSOP) in two cohorts of Swedish older adults. Wallengren O, Bosaeus I, Frändin K, Lissner L, Falk Erhag H, Wetterberg H, Rydberg Sterner T, Rydén L, Rothenberg E, Skoog I. BMC Geriatr; 2021 Oct 26; 21(1):600. PubMed ID: 34702174 [Abstract] [Full Text] [Related]
10. Consequences of applying the new EWGSOP2 guideline instead of the former EWGSOP guideline for sarcopenia case finding in older patients. Reiss J, Iglseder B, Alzner R, Mayr-Pirker B, Pirich C, Kässmann H, Kreutzer M, Dovjak P, Reiter R. Age Ageing; 2019 Sep 01; 48(5):719-724. PubMed ID: 31112221 [Abstract] [Full Text] [Related]
16. New versus old guidelines for sarcopenia classification: What is the impact on prevalence and health outcomes? Petermann-Rocha F, Chen M, Gray SR, Ho FK, Pell JP, Celis-Morales C. Age Ageing; 2020 Feb 27; 49(2):300-304. PubMed ID: 31728486 [Abstract] [Full Text] [Related]
18. [Diagnosis and prevalence of sarcopenia in long-term care homes: EWGSOP2 versus EWGSOP1]. Rodríguez-Rejón AI, Ruiz-López MD, Artacho Martín-Lagos R. Nutr Hosp; 2019 Oct 17; 36(5):1074-1080. PubMed ID: 31516007 [Abstract] [Full Text] [Related]